1.52
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CAMP?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.48
Offen:
$1.48
24-Stunden-Volumen:
20,356
Relative Volume:
0.20
Marktkapitalisierung:
$30.64M
Einnahmen:
$264.74M
Nettoeinkommen (Verlust:
$-49.71M
KGV:
-0.3711
EPS:
-4.0959
Netto-Cashflow:
$-43.55M
1W Leistung:
+0.00%
1M Leistung:
-8.98%
6M Leistung:
-68.53%
1J Leistung:
+280.00%
Camp 4 Therapeutics Corp Stock (CAMP) Company Profile
Firmenname
Camp 4 Therapeutics Corp
Sektor
Branche
Telefon
617-651-8867
Adresse
ONE KENDALL SQUARE, CAMBRIDGE, CA
Vergleichen Sie CAMP mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CAMP
Camp 4 Therapeutics Corp
|
1.52 | 29.84M | 264.74M | -49.71M | -43.55M | -4.0959 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Camp 4 Therapeutics Corp Stock (CAMP) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-27 | Eingeleitet | Wedbush | Outperform |
2024-11-05 | Eingeleitet | JP Morgan | Overweight |
2024-11-05 | Eingeleitet | Piper Sandler | Overweight |
2024-11-05 | Eingeleitet | William Blair | Outperform |
2022-08-16 | Hochstufung | Craig Hallum | Hold → Buy |
2021-12-22 | Herabstufung | Craig Hallum | Buy → Hold |
2021-09-24 | Bestätigt | Craig Hallum | Buy |
2021-06-25 | Bestätigt | Craig Hallum | Buy |
2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
2020-04-17 | Hochstufung | Jefferies | Hold → Buy |
2020-03-05 | Bestätigt | Craig Hallum | Buy |
2019-12-20 | Bestätigt | Craig Hallum | Buy |
2019-12-20 | Herabstufung | First Analysis Sec | Outperform → Neutral |
2019-06-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
2019-05-29 | Herabstufung | Goldman | Neutral → Sell |
2019-05-01 | Bestätigt | Craig Hallum | Buy |
2019-03-25 | Herabstufung | JP Morgan | Overweight → Neutral |
2019-01-25 | Hochstufung | JP Morgan | Neutral → Overweight |
2018-12-21 | Hochstufung | Craig Hallum | Hold → Buy |
2018-12-14 | Bestätigt | B. Riley FBR | Buy |
2018-12-11 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
2018-12-11 | Herabstufung | Northland Capital | Outperform → Market Perform |
2018-11-27 | Eingeleitet | Goldman | Neutral |
2018-10-15 | Eingeleitet | Jefferies | Hold |
2018-09-28 | Bestätigt | Craig Hallum | Hold |
2018-04-27 | Bestätigt | Craig Hallum | Hold |
2018-03-08 | Herabstufung | Craig Hallum | Buy → Hold |
2018-02-16 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
Alle ansehen
Camp 4 Therapeutics Corp Aktie (CAMP) Neueste Nachrichten
Can trapped investors hope for a rebound in Camp4 Therapeutics CorporationEarnings Miss & High Conviction Investment Ideas - Newser
Applying Elliott Wave Theory to Camp4 Therapeutics CorporationQuarterly Market Review & Daily Price Action Insights - Newser
How to read the order book for Camp4 Therapeutics CorporationJuly 2025 Price Swings & High Win Rate Trade Tips - Newser
Is Camp4 Therapeutics Corporation a defensive stockJuly 2025 PreEarnings & Consistent Growth Stock Picks - خودرو بانک
What are Camp4 Therapeutics Corporation’s earnings expectations2025 Earnings Impact & Weekly Stock Breakout Alerts - خودرو بانک
What is Camp4 Therapeutics Corporation’s TAM (Total Addressable Market)2025 Price Momentum & Weekly Momentum Stock Picks - خودرو بانک
Does Camp4 Therapeutics Corporation meet Warren Buffett’s criteriaQuarterly Profit Report & Technical Buy Zone Confirmations - خودرو بانک
Analyzing drawdowns of Camp4 Therapeutics Corporation with statistical toolsJuly 2025 Earnings & Smart Money Movement Alerts - Newser
Is PLCE’s growth already priced inPortfolio Value Summary & Reliable Intraday Trade Alerts - خودرو بانک
Will Camp4 Therapeutics Corporation rebound enough to break evenJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
Aug Shorts: Can Camp4 Therapeutics Corporation weather a recessionJuly 2025 Sector Moves & AI Based Trade Execution Alerts - خودرو بانک
Candlestick signals on Camp4 Therapeutics Corporation stock todayMarket Movers & Community Driven Trade Alerts - Newser
Real time scanner hits for Camp4 Therapeutics Corporation explainedQuarterly Profit Summary & Reliable Trade Execution Plans - Newser
Market reaction to Camp4 Therapeutics Corporation’s recent newsMarket Risk Report & Short-Term High Return Ideas - Newser
What to expect from Camp4 Therapeutics Corporation in the next 30 daysChart Signals & Verified Short-Term Plans - Newser
Sector ETF performance correlation with Camp4 Therapeutics Corporation2025 Key Highlights & Stepwise Swing Trade Plans - Newser
Is this a good reentry point in Camp4 Therapeutics CorporationJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - Newser
Can Camp4 Therapeutics Corporation deliver alphaJuly 2025 Analyst Calls & Technical Pattern Based Buy Signals - خودرو بانک
Using Python tools to backtest Camp4 Therapeutics Corporation strategiesPortfolio Risk Summary & Real-Time Market Trend Scan - Newser
Tick level data insight on Camp4 Therapeutics Corporation volatilityMarket Rally & Entry Point Confirmation Alerts - Newser
Is Camp4 Therapeutics Corporation showing signs of accumulationInflation Watch & Verified Stock Trade Ideas - Newser
Combining machine learning predictions for Camp4 Therapeutics CorporationPortfolio Growth Summary & Technical Buy Zone Confirmation - Newser
How liquid is FNLC stockJuly 2025 Closing Moves & Weekly High Return Stock Opportunities - خودرو بانک
Can Century Therapeutics Inc. ride the EV waveWeekly Stock Analysis & Weekly Breakout Stock Alerts - خودرو بانک
Real time social sentiment graph for Camp4 Therapeutics CorporationJuly 2025 Summary & Comprehensive Market Scan Reports - Newser
Will Camp4 Therapeutics Corporation outperform tech stocks2025 Year in Review & Safe Capital Growth Plans - خودرو بانک
Is Camp4 Therapeutics Corporation a speculative investmentJuly 2025 Rallies & Entry Point Strategy Guides - خودرو بانک
How sentiment analysis helps forecast Camp4 Therapeutics Corporation2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - Newser
Is Camp4 Therapeutics Corporation stock suitable for long term investing2025 Stock Rankings & Proven Capital Preservation Methods - خودرو بانک
Published on: 2025-09-02 23:28:06 - Newser
Will breakout in Camp4 Therapeutics Corporation lead to full recoveryQuarterly Investment Review & Safe Entry Momentum Tips - Newser
Does Camp4 Therapeutics Corporation show high probability of reboundJuly 2025 Macro Moves & Weekly Consistent Profit Watchlists - Newser
Will a bounce in Camp4 Therapeutics Corporation offer an exitQuarterly Profit Report & Risk Managed Investment Strategies - Newser
Is Camp4 Therapeutics Corporation stock a top performer YTDMarket Risk Analysis & AI Based Buy and Sell Signals - خودرو بانک
Can Camp4 Therapeutics Corporation rally from current levelsTrade Exit Summary & Verified Entry Point Signals - Newser
Published on: 2025-09-01 20:25:26 - Newser
Finanzdaten der Camp 4 Therapeutics Corp-Aktie (CAMP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Camp 4 Therapeutics Corp-Aktie (CAMP) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
AH Equity Partners Bio I, L.L. | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
727,272 |
7,999,992 |
1,579,885 |
Enavate Sciences GP, LLC | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
1,363,636 |
14,999,996 |
3,785,802 |
Polaris Management Co. VII, L. | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
909,090 |
5AM Partners VI, LLC | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
2,625,145 |
Nashat Amir | Director |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
909,090 |
Schwab Andrew J. | Director |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
2,625,145 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):